Clinical trial
Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely…
NCT00434668 · University Hospital, Antwerp, Other · Completed
Key facts
| NCT number | NCT00434668 |
|---|---|
| Title | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer |
| Official title | Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial |
| Acronym | TOLEDO |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Universiteit Antwerpen Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin/docetaxel, cisplatin/vinorelbine |
| Enrollment | 99 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Feb 13, 2007 |
| Last update posted | Nov 30, 2010 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: